Filing Details
- Accession Number:
- 0000885590-11-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-09 17:03:53
- Reporting Period:
- 2011-08-08
- Filing Date:
- 2011-08-09
- Accepted Time:
- 2011-08-09 17:03:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1232227 | Berghuis Katharine Stevenson | 7150 Missiassuga Road Mississauga A6 L5N8M5 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2011-08-08 | 1,000 | $39.73 | 10,397 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.72 to $39.74, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Includes 5,000 common shares and 4,397 RSUs that were previously reported.